|16.99||+0.07 / +0.41%|
Data as of 4:14pm ET
|16.93||-0.06 / -0.35%|
The 6 analysts offering 12-month price forecasts for Avanir Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 15.00. The median estimate represents a +0.06% increase from the last price of 16.99.
The current consensus among 6 polled investment analysts is to Hold stock in Avanir Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.